BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34298635)

  • 1. Phosphorylation of OGFOD1 by Cell Cycle-Dependent Kinase 7/9 Enhances the Transcriptional Activity of RNA Polymerase II in Breast Cancer Cells.
    Lee HT; Lee IH; Kim JH; Lee S; Kwak S; Suh MY; Hwang IY; Kang BG; Cha SS; Lee BI; Lee SE; Choi J; Roe JS; Cho EJ; Youn HD
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OGFOD1 is required for breast cancer cell proliferation and is associated with poor prognosis in breast cancer.
    Kim JH; Lee SM; Lee JH; Chun S; Kang BH; Kwak S; Roe JS; Kim TW; Kim H; Kim WH; Cho EJ; Youn HD
    Oncotarget; 2015 Aug; 6(23):19528-41. PubMed ID: 25909288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prolyl hydroxylase OGFOD1 promotes cancer cell proliferation by regulating the expression of cell cycle regulators.
    Fujisaki T; Saito K; Kikuchi T; Kondo E
    FEBS Lett; 2023 Apr; 597(8):1073-1085. PubMed ID: 36464654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OGFOD1, a member of the 2-oxoglutarate and iron dependent dioxygenase family, functions in ischemic signaling.
    Saito K; Adachi N; Koyama H; Matsushita M
    FEBS Lett; 2010 Aug; 584(15):3340-7. PubMed ID: 20579638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine-Phosphorylated STAT3 Promotes Tumorigenesis via Modulation of RNA Polymerase Transcriptional Activity.
    Balic JJ; Garama DJ; Saad MI; Yu L; West AC; West AJ; Livis T; Bhathal PS; Gough DJ; Jenkins BJ
    Cancer Res; 2019 Oct; 79(20):5272-5287. PubMed ID: 31481496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation and modulates translation and splicing.
    Stoehr A; Kennedy L; Yang Y; Patel S; Lin Y; Linask KL; Fergusson M; Zhu J; Gucek M; Zou J; Murphy E
    JCI Insight; 2019 May; 5(13):. PubMed ID: 31112528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OGFOD1 negatively regulated by miR-1224-5p promotes proliferation in human papillomavirus-infected laryngeal papillomas.
    Yin D; Wang Q; Wang S; Zhu G; Tang Q; Liu J
    Mol Genet Genomics; 2020 May; 295(3):675-684. PubMed ID: 32002629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation.
    Kim YK; Bourgeois CF; Isel C; Churcher MJ; Karn J
    Mol Cell Biol; 2002 Jul; 22(13):4622-37. PubMed ID: 12052871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The KIN28 gene is required both for RNA polymerase II mediated transcription and phosphorylation of the Rpb1p CTD.
    Valay JG; Simon M; Dubois MF; Bensaude O; Facca C; Faye G
    J Mol Biol; 1995 Jun; 249(3):535-44. PubMed ID: 7783209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of RNA polymerase II with the adenovirus-2 major late promoter is precluded by phosphorylation of the C-terminal domain of subunit IIa.
    Chesnut JD; Stephens JH; Dahmus ME
    J Biol Chem; 1992 May; 267(15):10500-6. PubMed ID: 1316903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle regulation and RNA polymerase II.
    Bregman DB; Pestell RG; Kidd VJ
    Front Biosci; 2000 Feb; 5():D244-57. PubMed ID: 10704151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive transcription elongation factor B phosphorylates hSPT5 and RNA polymerase II carboxyl-terminal domain independently of cyclin-dependent kinase-activating kinase.
    Kim JB; Sharp PA
    J Biol Chem; 2001 Apr; 276(15):12317-23. PubMed ID: 11145967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of the carboxy-terminal repeat domain in RNA polymerase II by cyclin-dependent kinases is sufficient to inhibit transcription.
    Gebara MM; Sayre MH; Corden JL
    J Cell Biochem; 1997 Mar; 64(3):390-402. PubMed ID: 9057097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer.
    Dasgupta S; Rajapakshe K; Zhu B; Nikolai BC; Yi P; Putluri N; Choi JM; Jung SY; Coarfa C; Westbrook TF; Zhang XH; Foulds CE; Tsai SY; Tsai MJ; O'Malley BW
    Nature; 2018 Apr; 556(7700):249-254. PubMed ID: 29615789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transition of RNA polymerase II from initiation to elongation is associated with phosphorylation of the carboxyl-terminal domain of subunit IIa.
    Payne JM; Laybourn PJ; Dahmus ME
    J Biol Chem; 1989 Nov; 264(33):19621-9. PubMed ID: 2584185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The carboxyl-terminal domain of RNA polymerase II is phosphorylated by a complex containing cdk9 and infected-cell protein 22 of herpes simplex virus 1.
    Durand LO; Advani SJ; Poon AP; Roizman B
    J Virol; 2005 Jun; 79(11):6757-62. PubMed ID: 15890914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of UBF at serine 388 is required for interaction with RNA polymerase I and activation of rDNA transcription.
    Voit R; Grummt I
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13631-6. PubMed ID: 11698641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter.
    Deng L; Ammosova T; Pumfery A; Kashanchi F; Nekhai S
    J Biol Chem; 2002 Sep; 277(37):33922-9. PubMed ID: 12114499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cdk-related kinase 9 regulates RNA polymerase II mediated transcription in Toxoplasma gondii.
    Deshmukh AS; Mitra P; Kolagani A; Gurupwar R
    Biochim Biophys Acta Gene Regul Mech; 2018 Jun; 1861(6):572-585. PubMed ID: 29466697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.